|
- Cell Gene Meeting on the Mesa
See which leading CGT companies attended the 2025 Meeting on the Mesa Registrants had the ability to request and schedule 1×1 partnering meetings with all registered attendees
- 2025 Meeting Agenda - Cell Gene Meeting on the Mesa
The 2025 Cell Gene Meeting on the Mesa was delivered in a hybrid format with live programming available over the course of three days Virtual registrants had access to all content via livestream during the program dates
- 2025 Meeting on the Mesa - bostonbiodevelopment. com
Boston Biodevelopment is thrilled to announce our sponsorship of the upcoming 2025 Meeting on the Mesa! This event has long been a place where ideas flourish and partnerships are forged, and we're honored to contribute to this ongoing tradition of innovation
- What Happened at Meeting on the Mesa 2025?
What Happened at Meeting on the Mesa 2025? This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment
- Mesa releases report from independent investigation on alleged park . . .
The Brief The City of Mesa has released the findings of an independent investigation into the allegations made against the city's Park Ranger Unit The allegations were made in April 2025 by a
- Partnering - Cell Gene Meeting on the Mesa
Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies
- Company Presentations - Cell Gene Meeting on the Mesa
This meeting featured 100+ presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies
- About the Event
Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies
|
|
|